Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Five HTAs related to eHealth published in July 2022 in Finland

In July 2022, the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) published on its website five Digi-HTAs in the fields of eHealth and in-vitro diagnostics, including the following technologies:

  • Orla INR Remote Monitoring (Orla DTx);
  • Monidor solution (Monidor Oy) for the implementation of intravenous fluid therapy;
  • Hygga Flow enterprise resource planning system (Hygga);
  • Unipercare service (SmartGroup) for home care and service centers;
  • Suvanto Care Safety Service (Suvanto Care Oy).

The DigiHTA assessment subareas include effectiveness, safety, costs, data security and data protection, usability, and accessibility. In each subarea, the product may receive a maximum score of 2; therefore, the maximum total score is 10.

The Orla INR Remote Monitoring (Orla DTx) received a total score of 10 (out of 10), which means that the use of the product is recommended. It was concluded that the Orla INR Remote Monitoring is suitable for self-measurement or self-care of patients provided with warfarin treatment. Special attention must be paid to patient selection and patient counseling.

Monidor solution (Monidor Oy) for the implementation of intravenous fluid therapy received a total score of 9 (out of 10), meaning that the organization considering the deployment of the product should note that in one key area (in this case, effectiveness) there are things to consider. For this technology, it was also concluded that it is suitable for monitoring the implementation of intravenous fluid therapy and enables its remote monitoring. The product facilitates the work of nursing staff, and its use can prevent complications of intravenous fluid therapy.

Hygga Flow enterprise resource planning system (Hygga) received a score of 9 (out of 10), which means that the organization considering the deployment of the product should note that in one key area (in this case, usability and accessibility) there are things to consider. It was also concluded that the Hygga Flow enterprise resource planning system is suited for planning the enterprise resources of health care units. Adopting the system requires a significant change in how a unit operates.

Unipercare service (SmartGroup) for home care and service centers received a score of 9 (out of 10), meaning that the organization considering the deployment of the product should note that in one key area (in this case, effectiveness) there are things to consider. It was also concluded that the Unipercare service is suitable for creating various remote digital services and contacts with the customer. It enables personalized services according to the customer's needs and social communication regardless of distance.

Suvanto Care Safety Service (Suvanto Care Oy) received a score of 8 (out of 10), which means that an organization considering the deployment of the product should note that in two key areas (in this case, effectiveness, usability and accessibility) there are things to consider. It was concluded that the Suvanto Care Safety Service is suitable for monitoring and ensuring the safety of a customer living at home. It enables the construction of a unique set of devices and the use of remote services. The service is suitable for assessing service needs and developing a home care service package. Research-based evidence of the effectiveness of the product on the customer's well-being is still scarce. There is sufficient research-based evidence on the economic benefits of the service.

The full details in Finnish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.